71.77
[1]. Te Dorsthorst DT, et al. In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach. Antimicrob Agents Chemother. Sep;46(9):98-9.
[]. Vermes A, et al. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother. Aug;46():171-9.
[]. Denis Fourches, et al. Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chem Res Toxicol. 1 Jan;(1):171-8.
[4]. Jin-Yan Liu, et al. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China. Res Microbiol. 15 Apr;166():15-61.
[5]. Lourdes Santana, et al. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem. 8 Nov 1;51(1):674-51.
H61
P8-P45-P51
GHS8